The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Insights into Cytokine–Receptor Interactions from Cytokine Engineering
Open accessAbstract
Cytokines exert a vast array of immunoregulatory actions critical to human biology and disease. However, the desired immunotherapeutic effects of native cytokines are often mitigated by toxicity or lack of efficacy, either of which results from cytokine receptor pleiotropy and/or undesired activation of off-target cells. As our understanding of the structural principles of cytokine–receptor interactions has advanced, mechanism-based manipulation of cytokine signaling through protein engineering has become an increasingly feasible and powerful approach. Modified cytokines, both agonists and antagonists, have been engineered with narrowed target cell specificities, and they have also yielded important mechanistic insights into cytokine biology and signaling. Here we review the theory and practice of cytokine engineering and rationalize the mechanisms of several engineered cytokines in the context of structure. We discuss specific examples of how structure-based cytokine engineering has opened new opportunities for cytokines as drugs, with a focus on the immunotherapeutic cytokines interferon, interleukin-2, and interleukin-4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on their dose-dependent selectivity for one or several JAKs, the JAK inhibitors (JAKi) exert a broad immunopharmacological impact because they block the signal transduction pathways of multiple type I (haematopoietic family) and type II (interferon) cytokine receptors17,214.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [214]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–203 of 203
Matthews, L., Chapman, S., Ramchandani, M. S., Lane, H. C., Davey, R. T., & Sereti, I. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.07.009 · Cited by 11
Structural analogs of interleukin-2: a point mutation that facilitates biological response.
Chang, D. Z., Tasayco, M. L., & Ciardelli, T. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08520-7 · Cited by 11
Davey, R. T., Pertel, P. E., Benson, A., Cassell, D. J., Gazzard, B., Holodniy, M., Lalezari, J. P., Lévy, Y., Mitsuyasu, R. T., Palella, F. J., et al. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0064 · Cited by 7
Research works printed but not linked: 2
- Gesbert F, 2004, Curr. Top. Microbiol. Immunol., 286, 119
- Debinski W, 1995, Clin. Cancer Res., 1, 1253
Cited by
Sorted by citations
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
The molecular details of cytokine signaling via the JAK/STAT pathway
Morris, R., Kershaw, N. J., & Babon, J. J. (2018) · Protein Science · doi:10.1002/pro.3519 · Cited by 943
Interleukin-6 Family CytokinesPreprint
Rose‐John, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 846
The JAK-STAT pathway at 30: Much learned, much more to do
Philips, R. L., Wang, Y., Cheon, H., Kanno, Y., Gadina, M., Sartorelli, V., Horvath, C. M., Darnell, J. E., Jr., Stark, G. R., & O’Shea, J. J. (2022) · Cell · doi:10.1016/j.cell.2022.09.023 · Cited by 755
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Metadata
- Authors
- Spangler, J. B., Moraga, I., Mendoza, J. L., & Garcia, K. C.
- Affiliations
- Howard Hughes Medical Institute (US)
- Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305;, , ,
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2015-03-21
- Volume
- 33
- Issue
- 1
- Pages
- 139-167
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- PMC
- PMC4445396
- OpenAlex
- W2098212097
- Cited by
- 304
- References
- 202
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 38 · 2023: 32 · 2022: 48 · 2021: 48 · 2020: 24 · 2019: 16 · 2018: 18 · 2017: 18 · 2016: 6 · 2015: 7
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Cancer Institute (K01CA175127)
- National Institute of Allergy and Infectious Diseases (R01 AI51321, R37AI051321, R01AI051321)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- cytokine engineering, cytokine-cytokine receptor interaction, cytokine signaling, structure-based protein engineering, cytokine antagonists, target cell specificity, cytokine toxicity, immunotherapy, interferon, interleukin-2, IL-4
- MeSH terms
- Animals, Extracellular Space, Genetic Engineering, Humans, Protein Binding, Signal Transduction, Cytokines, Receptors, Cytokine, Protein Transport, Intracellular Space
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
